These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 18505067

  • 1. Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
    Barone C, Grillo R, Dongiovanni D, Birocco N, Rampino M, Redda MG, Garibaldi E, Munoz F, Pecorari G, Cavalot A, Garzinodemo P, Buffoni L, Ciuffreda L, Ricardi U, Cortesina G, Giordano C, Fasolis M, Berrone S, Bertetto O, Schena M.
    Anticancer Res; 2008; 28(2B):1285-91. PubMed ID: 18505067
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.
    J Clin Oncol; 2004 Aug 01; 22(15):3061-9. PubMed ID: 15284256
    [Abstract] [Full Text] [Related]

  • 3. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 4. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK.
    Cancer; 2002 Jul 15; 95(2):322-30. PubMed ID: 12124833
    [Abstract] [Full Text] [Related]

  • 6. Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: comparison of two different schedules.
    Moreno-Jiménez M, Valero J, López-Picazo JM, Arbea L, Aristu J, Cambeiro M, Alcalde J, Martínez-Monge R.
    Am J Clin Oncol; 2010 Apr 15; 33(2):137-43. PubMed ID: 19786847
    [Abstract] [Full Text] [Related]

  • 7. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, Witt ME, Brockstein BE, List MA, Portugal L, Pelzer H, Weichselbaum RR, Vokes EE.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.
    Oral Oncol; 2006 Aug 01; 42(7):675-84. PubMed ID: 16731029
    [Abstract] [Full Text] [Related]

  • 10. Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study.
    Chougule PB, Akhtar MS, Akerley W, Ready N, Safran H, McRae R, Nigri P, Bellino J, Koness J, Radie-Keane K, Wanebo H.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):58-63. PubMed ID: 10210541
    [Abstract] [Full Text] [Related]

  • 11. Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.
    Hitt R, Jimeno A, Millán JM, Castellano D, Cortés-Funes H.
    Cancer; 2004 Aug 15; 101(4):768-75. PubMed ID: 15305408
    [Abstract] [Full Text] [Related]

  • 12. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ, Liu SP, Wang XE.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):821-7. PubMed ID: 20207507
    [Abstract] [Full Text] [Related]

  • 13. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H, Tsukuda M, Watai K.
    Cancer Chemother Pharmacol; 2007 Aug 01; 60(3):399-406. PubMed ID: 17096160
    [Abstract] [Full Text] [Related]

  • 14. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M, Taguchi T.
    Cancer Chemother Pharmacol; 2007 May 01; 59(6):789-94. PubMed ID: 17053926
    [Abstract] [Full Text] [Related]

  • 15. Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: preliminary results of two pilot trials using paclitaxel and cisplatin.
    Flood W, Lee DJ, Trotti A, Spencer S, Murphy B, Khuri F, DeConti R, Wheeler R, Forastiere AA.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):64-9. PubMed ID: 10210542
    [Abstract] [Full Text] [Related]

  • 16. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.
    Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E.
    J Clin Oncol; 2004 Jul 15; 22(14):2856-64. PubMed ID: 15254053
    [Abstract] [Full Text] [Related]

  • 17. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB.
    Cancer; 2009 Oct 01; 115(19):4514-23. PubMed ID: 19634161
    [Abstract] [Full Text] [Related]

  • 18. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ, Chung JS, Shin HJ, Cho GJ, Wang SG, Lee BJ, Cho BM, Joo YD, Sohn CH.
    J Laryngol Otol; 2008 Aug 01; 122(8):848-53. PubMed ID: 18047761
    [Abstract] [Full Text] [Related]

  • 19. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL, Chu PY, Tai SK, Wang YF, Yang MH, Wang LW, Lirng JF, Chang SY.
    Jpn J Clin Oncol; 2011 Oct 01; 41(10):1182-93. PubMed ID: 21862506
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM, Murphy BA, Rosenthal DI, Pandya KJ, Glück S, Brizel HE, Meredith RF, Berger D, Chen MG, Mendenhall W.
    J Clin Oncol; 2008 May 20; 26(15):2489-96. PubMed ID: 18487568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.